entertainment -WSS

entertainment

author：leisure time 2025-10-02 11:07:47 - browse：73121

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

explore

leisure time

WSS

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

How I ended up pumping milk in a bathroom stall at JPM 2024

A biotech analyst on neuroscience, placebo effect, not over

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

The SUPPORT Act is critical to fighting the opioid crisis

For Cytokinetics, FDA rejection of heart drug would help, not hinder

focus

entertainment

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

As demand for Covid shots wanes, Moderna seeks its next success

Wegovy’s successful heart trial raises vital question about weight loss

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wegovy trial has doctors encouraged over new possibilities

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Hepatitis C has a cure — but many Americans still lack access to it

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

hotspot

In same hospitals, Black patients receive fewer opioids than white patients

The nurse manager staffing crisis is hurting patients

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

DeSantis can now import cheaper drugs. But will Biden get credit?

How I ended up pumping milk in a bathroom stall at JPM 2024

focus

explore

leisure time

hotspot